Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling

References

• Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012;36:237–48
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2013;63:11–30
   PubMed Web of Science ®Google Scholar
• DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics. CA Cancer J Clin 2011;61:408–18
   Web of Science ®Google Scholar
• Wiebe JP, Zhang G, Welch I, Cadieux-Pitre HAT. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors. Breast Cancer Res 2013;15:R38
   PubMed Web of Science ®Google Scholar
• Anderson BO, Yip CH, Ramsey SD, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J 2006;12:54–69
   PubMed Web of Science ®Google Scholar
• Tinoco G, Warsch S, Glück S, et al. Treating breast cancer in the 21st century: emerging biological therapies. J Cancer 2013;4:117–32
   PubMed Web of Science ®Google Scholar
• Wind NS, Holen I. Multidrug resistance in breast cancer: from in vitro models to clinical studies. Int J Breast Cancer 2011;2011:1–12
   Google Scholar
• Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010;9:447–64
   PubMed Web of Science ®Google Scholar
• Lee J, Lim KT. Phytoglycoprotein (38 kDa) induces cell cycle (G/G) arrest and apoptosis in HepG2 cells. J Cell Biochem 2011;112:3129–39
   PubMed Web of Science ®Google Scholar
• Kim JE, Kim JY, Lee KW, Lee HJ. Cancer chemopreventive effects of lactic acid bacteria. J Microbiol Biotechnol 2007;17:1227–35
   PubMed Web of Science ®Google Scholar
• Kim MK, Min J, Choi BY, et al. Discovery of cyclin-dependent kinase inhibitor, CR229, using structure-based drug screening. J Microbiol Biotechnol 2007;17:1712–16
   PubMed Web of Science ®Google Scholar
• Lim H, Oh HL, Lee CH. Effects of Aralia continentalis root extract on cell antiproliferation and apoptosis in human promyelocytic leukemia HL-60 cells. J Microbiol Biotechnol 2006;16:139–1404
   Google Scholar
• Lim H, Lim Y, Cho YH, Lee CH. Induction of apoptosis in the HepG2 cells by HY53, a novel natural compound isolated from bauhinia forficata. J Microbiol Biotechnol 2006;16:1262–8
   Web of Science ®Google Scholar
• Jim JH, Sung KJ, Cho MC, et al. Antitumor effect of soluble beta-1,3-glucan from Agrobacterium sp. R259 KCTC 1019. J Microbiol Biotechnol 2007;17:1513–20
   Google Scholar
• Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 2004;279:12755–62
   PubMed Web of Science ®Google Scholar
• Olson JM, Hallahan AR. p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med 2004;10:125–9
   PubMed Web of Science ®Google Scholar
• Cellurale C, Girnius N, Jiang F, et al. Role of JNK in mammary gland development and breast cancer. Cancer Res 2012;72:472–81
   PubMed Web of Science ®Google Scholar
• Garcia CC, Brousse BN, Carlucci MJ, et al. Inhibitory effect of thiosemicarbazone derivatives on Junin virus replication in vitro. Antivir Chem Chemother 2003;14:99–105
   PubMedGoogle Scholar
• Sau DK, Butcher RJ, Chaudhuri S, Saha N. Spectroscopic, structural and antibacterial properties of Cu(II) complexes with bio-relevant 5-methy-3-formylpyrazole N(4)-benzyl-N(4)-methylthiosemicarbazone. Mol Cell Biochem 2003;253:21–9
   PubMed Web of Science ®Google Scholar
• Đilović I, Rubčić M, Vrdoljak V, et al. Novel thiosemicarbazone derivatives as potential antitumor agents: synthesis, physicochemical and structural properties, DNA interactions and antiproliferative activity. Bioorg Med Chem 2008;16:5189–98
   PubMed Web of Science ®Google Scholar
• Vandresen F, Falzirolli H, Batista SAA. Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines. Eur J Med Chem 2014;79:110–16
   PubMed Web of Science ®Google Scholar
• Hu K, Yang Z, Pan S-S, et al. Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives. Eur J Med Chem 2010;45:3453–8
   PubMed Web of Science ®Google Scholar
• Murren J, Modiano M, Clairmont C, et al. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors. Clin Cancer Res 2003;9:4092–100
   PubMed Web of Science ®Google Scholar
• Abu-Zaied MAZ, Nawwar GAM, Swellem RH, El-Sayed SH. Synthesis and screening of new 5-substituted-1,3,4-oxadiazole-2-thioglycosides as potent anticancer agents. Pharmacol Pharm 2012;3:254–61
   Google Scholar
• Kumar D, Sundaree S, Johnson EO, Shah K. An efficient synthesis and biological study of novel in-dolyl-1,3,4-oxadiazoles as potent anticancer agents. Bioorg Med Chem Lett 2009;19:4492–4
   PubMed Web of Science ®Google Scholar
• Zhang X-M, Qiu M, Sun J, et al. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents. Bioorg Med Chem 2011;19:6518–24
   PubMed Web of Science ®Google Scholar
• Ramazani A, Khoobi M, Torkaman Ar, et al. One-pot, four-component synthesis of novel cytotoxic agents1-(5-aryl-1,3,4-oxadiazol-2-yl)-1-(1H-pyrrol-2-yl)methanamines. Eur J Med Chem 2014;78:151–6
   PubMed Web of Science ®Google Scholar
• Aboraia AS, Abdel-Rahman HM, Mahfouz NM, El-Gendy MA. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents. Bioorg Med Chem 2006;14:1236–46
   PubMed Web of Science ®Google Scholar
• Abdel Rahman DE. Synthesis, quantitative structure-activity relationship and biological evaluation of 1,3,4-oxadiazole derivatives possessing diphenylamine moiety as potential anticancer agents. Chem Pharm Bull 2013;61:151–9
   PubMed Web of Science ®Google Scholar
• Guimarães CRW, Boger DL, Jorgensen WL. Elucidation of fatty acid amide hydrolase inhibition by potent α ketoheterocycle derivatives from Monte Carlo simulations. J Am Chem Soc 2005;127:17377–84
   PubMed Web of Science ®Google Scholar
• O'Boyle NM, Greene LM, Bergin O, et al. Synthesis, evaluation and structural studies of antiproliferative tubulin-targeting azetidin-2-ones. Bioorg Med Chem 2011;19:2306–25
   PubMed Web of Science ®Google Scholar
• Picotin G, Miginiac P. Activation of zinc by trimethylchlorosilane. An improved procedure for the preparation of beta-hydroxy esters from ethyl bromoacetate and aldehydes or ketones (Reformatsky reaction). J Org Chem 1987;52:4796–8
   Web of Science ®Google Scholar
• Frankenfeld JW, Werner JJ. Improved procedure for the Reformatsky reaction of aliphatic aldehydes and ethyl bromoacetate. J Org Chem 1969;34:3689–91
   Web of Science ®Google Scholar
• Newman MS, Kutner A. New reactions involving alkaline treatment of 3-nitroso-2-oxazolidones. J Am Chem Soc 1951;73:4199–204
   Web of Science ®Google Scholar
• Krystof V, Cankar P, Frýsová I, et al. 4-Arylazo-3,5-diamino-1H-pyrazole CDK inhibitors:SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. J Med Chem 2006;49:6500–9
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman HM, Hussein MA. Synthesis of beta-hydroxypropanoic acid derivatives as potential anti-inflammatory, analgesic and antimicrobial agents. Arch Pharm (Weinheim) 2006;339:378–87
   PubMed Web of Science ®Google Scholar
• Shrivastava HY, Ravikumar T, Shanmugasundaram N, et al. Cytotoxicity studies of chromium (III) complexes on human dermal fibroblasts. Free Radical Bio Med 2005;38:58–69
   PubMed Web of Science ®Google Scholar
• Zhuang S, Schnellmann RG. A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 2006;319:991–7
   PubMed Web of Science ®Google Scholar
• Kim H, Khursigara G, Franke TF, Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 2001;21:893–901
   PubMed Web of Science ®Google Scholar
• Haftchenary S, Avadisian M, Gunning PT. Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report. Anticancer Drugs 2011;22:115–27
   PubMed Web of Science ®Google Scholar
• Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009;9:537–49
   PubMed Web of Science ®Google Scholar
• Zhao H, Serby MD, Xin Z, et al. Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors. J Med Chem 2006;49:4455–8
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE) 2009.10, Montréal, Canada: Chemical Computing Group Inc; 2009. Available from: http://www.chemcomp.com
   Google Scholar